Pharmaceutical Business Review
Return to: PBR Home | Suppliers

INC Research - CRO for Drug and Device Development News

INC Research - CRO for Drug and Device Development

INC Research Hits Major Milestone with Trusted Process QuickStart Phase INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is proud to announce that it has recently completed its 300th QuickStart® Camp, which is a unique, week-long kick-off meeting with the customer that is designed to reconcile expectations and build study ownership by the entire project team right up front. QuickStart Camp is part of the second phase in INC Research's Trusted Process®, the company's proven, metrics-driven clinical trial outsourcing methodology. When compared to industry benchmarks established by CMR International Institute for Regulatory Science, customers experience 35 percent faster project startup time after experiencing QuickStart.
View press release
INC Research to Acquire Kendle International for $15.25 per Share in Cash INC Research, LLC, a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, and Kendle International Inc. (Nasdaq: KNDL), today jointly announced a definitive merger agreement under which INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million. Kendle is a leading global CRO with extensive expertise in Phase I-IV clinical development and more than 3,000 associates in 31 countries worldwide.
View press release
INC Research Acquires Leading Australian CRO Trident Clinical Research INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, today announced the acquisition of Trident Clinical Research to expand its clinical trials outsourcing footprint and expertise in Australia, New Zealand and India. Under the terms of the agreement, Trident will become a wholly owned affiliate of INC Research and will operate as Trident Clinical Research, an INC Research company through its offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai. Trident’s operation in Mumbai will increase the reach of INC Research’s already sizeable clinical and data operations located in Gurgaon, India.
View press release
INC Research Rounds Out Pediatrics Team Dr Erik Deurell brings diverse clinical pediatrics experience to global CRO.
View press release
INC Research Named Top 10 CRO in CenterWatch Global Survey Global CRO ranks ninth in first global investigative site survey.
View press release
INC Research's Jen Catena Davis Named a "US Clinical Researcher of the Year" Award Finalist INC Research®, LLC., a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is proud to announce that Jen Catena Davis, CCRA, a clinical research associate III at INC Research, has been named a finalist in PharmaTimes’ US Clinical Researcher of the Year Award in the CRA/Site Manager category.
View press release
INC Research Continues to Grow Alliance Partnership Team with Bruce Wakeman New VP of Alliance Development brings therapeutic and clinical delivery Alliance expertise.
View press release
INC Research Grows Clinical Trials Services Team in India to Manage Growing Demands in Emerging Region New leadership in Gurgaon office further strengthens clinical trials outsourcing services and data operations.
View press release
INC Research Adds AVOS Life Sciences to Strengthen Strategic and Regulatory Consulting Group Powerhouse team expands consulting capabilities with unparalleled expertise and analytical tools.
View press release
Patrick Melvin Joins Oncology Leadership Team at INC Research Therapeutic and operational clinical trials expert strengthens oncology capabilities.
View press release
INC Research Augments Pediatric Clinical Trial Capabilities Kathy Bohannon brings valuable multi-discipline therapeutic expertise to pediatric trial design and management.
View press release
INC Research Sponsors FierceBiotech Clinical Insights Executive Breakfast on Designing the Ideal Phase II Trial Exclusive gathering to feature expert panel offering perspectives on the latest trends and technologies for mid-stage studies.
View press release